EN
登录

医疗科技公司Dawn Medical Technologies收购越南Pinnacle Health控股股权

Dawn Medical Technologies acquires controlling interest in Pinnacle Health in Vietnam

BioSpectrum Asia 等信源发布 2026-04-23 15:26

可切换为仅中文


Singapore-based Dawn Medical Technologies, CBC Group's MedTech commercialisation platform, has announced the acquisition of a controlling interest in Pinnacle Health Equipment Joint Stock Company, one of Vietnam's largest and most established full-service MedTech distributors.

新加坡的黎明医疗科技公司(Dawn Medical Technologies),CBC集团的医疗技术商业化平台,宣布收购越南最大、最成熟的全方位医疗技术分销商之一——顶点健康设备股份公司(Pinnacle Health Equipment Joint Stock Company)的控股权。

This strategic transaction marks Dawn's entry into the fast-growing Vietnamese market and CBC Group's first acquisition

这一战略性交易标志着德恩进入快速增长的越南市场,也是CBC集团的首次收购。

in the MedTech space

在医疗技术领域

in Southeast Asia.

在东南亚。

Backed by CBC Group, Asia's largest healthcare-dedicated asset management firm, Dawn is building a leading MedTech commercialization platform that connects upstream sourcing capabilities with downstream commercial excellence to expand access to high-quality, affordable medical solutions across emerging markets anchored in Southeast Asia..

在亚洲最大的专注医疗保健的资产管理公司CBC集团的支持下,Dawn正在建立一个领先的医疗技术商业化平台,该平台将上游的采购能力与下游的商业优势相结合,以扩大东南亚新兴市场中高质量、可负担的医疗解决方案的获取途径。

Founded in 2015, Pinnacle Health has earned a strong reputation for deep product expertise and high quality customer service. Headquartered in Ho Chi Minh City, the company represents leading global MedTech companies, and serves hospitals and clinics nationwide.

成立于2015年,Pinnacle Health凭借深厚的产品专业知识和高质量的客户服务赢得了良好的声誉。公司总部位于胡志明市,代表全球领先的医疗技术公司,为全国各地的医院和诊所提供服务。

With Vietnam's healthcare expenditure expected to grow at 8 – 9% annually, the acquisition provides Dawn with an immediate, scaled, and highly respected local platform.

随着越南医疗支出预计每年增长8%-9%,此次收购为Dawn提供了一个即时、规模化且备受尊敬的本地平台。

This acquisition aligns with Dawn's strategy to lead MedTech commercialisation in the region by consolidating fragmented markets and leveraging regulatory and commercial excellence across Asia to improve access to critical medical technologies.

此次收购符合Dawn通过整合分散的市场并利用亚洲各地的监管和商业优势来推动该地区医疗技术商业化的战略,以改善对关键医疗技术的获取。